CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy

SIMPLE SUMMARY: In this study, we first reported the infiltration and prognostic value of CXCR6+TAMs in all stages of colon cancer patients and assessed predictive ability as a biomarker for different duration adjuvant chemotherapy regimens in the primary cohort and validation cohort Patients with h...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jiang, Lin, Songbin, Mao, Yihao, Xu, Yuqiu, Zhang, Zhiyuan, Wu, Qi, Chen, Yijiao, Wei, Ye, Feng, Qingyang, Xu, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562861/
https://www.ncbi.nlm.nih.gov/pubmed/36230570
http://dx.doi.org/10.3390/cancers14194646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562861/
https://www.ncbi.nlm.nih.gov/pubmed/36230570
http://dx.doi.org/10.3390/cancers14194646

Ejemplares similares